Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis.
about
SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.Interpretation of cardiovascular outcome trials in type 2 diabetes needs a multiaxial approach.Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data.Metabolic Syndrome and its Profound Effect on Prevalence of Ischemic Stroke.
P2860
Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis.
@en
type
label
Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis.
@en
prefLabel
Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis.
@en
P2860
P1476
Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis.
@en
P2093
Johansen OE
P2860
P304
P356
10.1080/00365510701408558
P577
2007-01-01T00:00:00Z